FORT LEE, N.J., June 21, 2012 /PRNewswire/ -- Herborium Group,
Inc., ( HBRM) www.herborium.com, a Botanical Therapeutics®
Company announces today that it has begun a commercialization of
its proprietary all herbal ingredients based Energy
Drink and entered into manufacturing of the product.
Herborium energy product is expected to be on the market
in the Fall of 2012 and will complement the Company's
sexual health product line. The energy drink category
represents $8 Billion market and is
the fastest growing niche in the beverage business, up 16% over the
past year.
Herborium's all herbal energy product represents
the most demanded subcategory of energy drinks as it is all
natural and does not contain caffeine, sugar and Vitamin B12, B6 or
B3 that in larger amounts are considered dangerous, and are
presently included in most energy drinks on the market. There is
over 5500 caffeine overdoses in the US every year, and about 45%
occurs in those who are younger than 19-years old. Several
countries and states have debated or restricted sales and
advertising of those energy drinks that contain caffeine.
Denmark, Turkey and Uruguay have banned them; Norway prohibits sales to children under
15.
"We are extremely excited to move into the commercialization
stage for our unique healthy energy product that can also fight jet
lag and has no adverse effects. Our product contains a proprietary
blend of herbal extracts that provide for an immediate lift of
energy and alertness as well as for longer lasting beneficial
effects, without jittery feeling and a "crash" associated with
caffeine and sugar containing drinks. We believe that this is the
right time to enter this rapidly growing market niche that also
interfaces with a $50 billion health
food sector. By using science of Botanical
Therapeutics® to meet growing market
demand for energy drinks and natural products we expect to achieve
an exponential growth of our market share and revenues over the
next 12 months," stated Dr. Agnes
Olszewski, Chairman and CEO of Herborium.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to establish
and maintain a differential advantage. The company sales its
products in the US and Europe. For
more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.